Hasmukh Jain

Indian Institute of Technology Roorkee — India

Medicine · Health Sciences

17h-index1.1kcitations255works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(70), Acute Myeloid Leukemia Research(41), Acute Lymphoblastic Leukemia research(40), Chronic Lymphocytic Leukemia Research(34), Multiple Myeloma Research and Treatments(24)

Publications255 total

Broadening CAR-T access: lessons from real-world implementation of talicabtagene autoleucel in India
Blood Immunology & Cellular Therapy·2025Open Access
Early time to relapse as a survival prognosticator in nodal mature T-cell lymphomas: results from the PETAL consortium
Blood·2025· 1 citedOpen Access
Multiple Myeloma in Young Adults—Insights From a Tertiary Care Cancer Centre in India
eJHaem·2025Open Access
Presenting features, treatment patterns and predictors of outcomes in AL amyloidosis at a tertirary care cancer centre
Blood·2025Open Access
Early time-to-relapse as a predictor of survival in mature T-cell/NK-cell lymphomas: Results from the PETAL consortium
Blood·2025
Early use of talicabtagene autoleucel in r/r B-acute lymphoblastic leukemia is cost-effective: Improved efficacy, reduced toxicity and healthcare resource utilization support affordable access
Blood·2025Open Access
Less‑intensive therapy in newly diagnosed acute myeloid leuekmia (AML) in India: Real-world adoption and prognostic utility of ELN‑LI and ELN‑2022 classification
Blood·2025
Trial in progress: Phase I trial to evaluate safety of oral azacytidine in combination with pomalidomide as maintenance therapy in AML
Blood·2025Open Access
Outcomes with ATO/ATRA based regimen in apml - steroid induced toxicities are a concern in LMICs
Blood·2025Open Access
Figure S5 from IL-9 Promotes Migratory Dissemination of Malignant T Cells by Activating the HIF-1α–Cofilin-1 Axis in Cutaneous T-cell Lymphoma
2025Open Access
Figure S4 from IL-9 Promotes Migratory Dissemination of Malignant T Cells by Activating the HIF-1α–Cofilin-1 Axis in Cutaneous T-cell Lymphoma
2025Open Access
Data from IL-9 Promotes Migratory Dissemination of Malignant T Cells by Activating the HIF-1α–Cofilin-1 Axis in Cutaneous T-cell Lymphoma
2025Open Access
Supplementary Figure Legends from IL-9 Promotes Migratory Dissemination of Malignant T Cells by Activating the HIF-1α–Cofilin-1 Axis in Cutaneous T-cell Lymphoma
2025Open Access
Figure S1 from IL-9 Promotes Migratory Dissemination of Malignant T Cells by Activating the HIF-1α–Cofilin-1 Axis in Cutaneous T-cell Lymphoma
2025Open Access
Figure S2 from IL-9 Promotes Migratory Dissemination of Malignant T Cells by Activating the HIF-1α–Cofilin-1 Axis in Cutaneous T-cell Lymphoma
2025Open Access
Table S1 from IL-9 Promotes Migratory Dissemination of Malignant T Cells by Activating the HIF-1α–Cofilin-1 Axis in Cutaneous T-cell Lymphoma
2025Open Access
Figure S6 from IL-9 Promotes Migratory Dissemination of Malignant T Cells by Activating the HIF-1α–Cofilin-1 Axis in Cutaneous T-cell Lymphoma
2025Open Access
Table S2 from IL-9 Promotes Migratory Dissemination of Malignant T Cells by Activating the HIF-1α–Cofilin-1 Axis in Cutaneous T-cell Lymphoma
2025Open Access
Figure S3 from IL-9 Promotes Migratory Dissemination of Malignant T Cells by Activating the HIF-1α–Cofilin-1 Axis in Cutaneous T-cell Lymphoma
2025Open Access
Clinical Characteristics and Long Term Outcomes of POEMS Syndrome from a Tertiary Care Cancer Center
Clinical Lymphoma Myeloma & Leukemia·2025
page 1 of 13Next →

Frequent Co-authors

Manju Sengar(38), Bhausaheb Bagal(28), Prashant Tembhare(22), Papagudi Ganesan Subramanian(22), Nikhil Patkar(21), Sumeet Gujral(19), Navin Khattry(17), Lingaraj Nayak(14), Anant Gokarn(12), Gaurav Chatterjee(11), Gaurav Narula(11), Sridhar Epari(11), Avinash Bonda(10), Jayashree Thorat(10), Hari Menon(9), Swapnali Joshi(8), Shruti Chaudhary(8), Nilesh Deshpande(8), Dhanalaxmi Shetty(8), Sachin Punatar(8)